A carregar...
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study
Laquinimod is a novel orally administered drug for the treatment of relapsing remitting multiple sclerosis (RRMS). In this immunological substudy of the phase III Assessment of Oral Laquinimod in Preventing Progression of MS (ALLEGRO) trial, we performed an ex vivo and in vitro analysis of effects e...
Na minha lista:
| Publicado no: | Immun Inflamm Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BlackWell Publishing Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4444148/ https://ncbi.nlm.nih.gov/pubmed/26029365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.42 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|